(Q34732964)

4 August 2017

title

Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes (English)

1 reference

4 August 2017

Allison B Rosen

1

1 reference

4 August 2017

Andrew J Karter

2

1 reference

4 August 2017

Jennifer Y Liu

3

1 reference

4 August 2017

Joe V Selby

4

1 reference

4 August 2017

Eric C Schneider

5

1 reference

4 August 2017

publication date

1 June 2004

1 reference

Journal of General Internal Medicine

4 August 2017

published in

1 reference

4 August 2017

volume

19

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

669-675

1 reference

https://scigraph.springernature.com/pub.10.1111/j.1525-1497.2004.30264.x

4 August 2017

exact match

0 references

cites work

Are angiotensin converting enzyme inhibitors and angiotensin receptor blockers becoming the treatment of choice in African-Americans?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Racial disparities in the quality of care for enrollees in medicare managed care

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Impact of sociodemographic case mix on the HEDIS measures of health plan quality

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Racial differences in use of cancer prevention services among older Americans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Using angiotensin converting enzyme inhibitors in African-American hypertensives: a new approach to treating hypertension and preventing target-organ damage

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

7 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

7 July 2018

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Some evidence refuting the HMO "favorable selection" hypothesis: the case of Kaiser Permanente

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

End-stage renal disease in specific ethnic and racial groups: risk factors and benefits of antihypertensive therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

ACE inhibitor-induced angioedema. Incidence, prevention and management

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Linking automated databases for research in managed care settings

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Prognosis of diabetic patients on dialysis: analysis of Lombardy Registry data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Racial differences in the use of revascularization procedures after coronary angiography

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study

7 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Ethnic disparities in diabetic complications in an insured population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Effects of race and income on mortality and use of services among Medicare beneficiaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Racial disparity in influenza vaccination: does managed care narrow the gap between African Americans and whites?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Excess costs of medical care for patients with diabetes in a managed care population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Glycemic control and heart failure among adult patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Racial Variation in the Use of Coronary-Revascularization Procedures — Are the Differences Real? Do They Matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

Self-Reported vs Administrative Race/Ethnicity Data and Study Results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2004.30264.X

The continuing epidemics of obesity and diabetes in the United States

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Use of microalbuminuria testing in persons with type 2 diabetes: are the right patients being tested?

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1492381

Why patients with diabetes, hypertension and/or proteinuria are not on angiotensin converting enzyme inhibitors

26 October 2018

1 reference

12 December 2020

Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group

1 reference

12 December 2020

Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives

1 reference

12 December 2020

Racial differences in the elderly's use of medical procedures and diagnostic tests

1 reference

12 December 2020

Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes

1 reference

12 December 2020

Prevention of end-stage renal disease due to type 2 diabetes

1 reference

12 December 2020

Improving use of ACE inhibitors in diabetic nephropathy

1 reference

12 December 2020

The care of patients with diabetic nephropathy: audit, feedback, and improvement

1 reference

12 December 2020

Characteristics of patients referred for treatment of end-stage renal disease in a defined population

1 reference

12 December 2020

The use of ACE inhibitors as renoprotective agents in Medicaid patients with diabetes

1 reference

12 December 2020

Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney F

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care

1 reference

12 December 2020

10.1111/J.1525-1497.2004.30264.X

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1050307252

0 references

Fatcat ID

release_ifrs4zoyqnbydkzkygaruo4mga

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ifrs4zoyqnbydkzkygaruo4mga

24 November 2022

mapped directly with Wikidata item

PMC publication ID

1492381

1 reference

4 August 2017

1 reference